Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Highly experienced ex-Delta One trader with 17 years of experience trading arbitrage and related strategies across Asian markets.

Exempt Financial Adviser (EFA) under CrossASEAN Research Pte Ltd.

It is important to note that the information provided by Periscope Analytics is based on publicly available data and own knowledge, which has been gathered and synthesized from a variety of sources. While every effort has been made to ensure the accuracy and completeness of the information provided, it is not guaranteed to be free from errors or omissions.

All forecasts and estimates are based on information that has been obtained from public sources that are considered to be reliable. The sources include, but are not limited to, company announcements, exchange filings, ETF and other passive investment vehicle holdings, and free float and volume data from third-party data providers. Periscope Analytics does not guarantee the accuracy and completeness of the forecasts, estimates and/or other information.

Pan-Asia Index Rebalances/ Events/ Delta One

Sensex Index Rebalance: Dr. Reddy IN, Tata Steel OUT

Sensex June21 Index Rebalance Preview: Deletion Almost Certain; Addition a Wild Card for Now

Sensex June21 Index Rebalance Preview: Index Committee Has a Decision to Make

Sensex Index Review - Bajaj Finserv In, Hero MotoCorp Out

MSCI to Update India Foreign Ownership Limits

Sensex Index Rebalance Preview: Early Look Sees One Change, Maybe Two

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

MSCI Nov20 Index Rebalance Preview - India

Index Rebalance

Dr. Reddy's Laboratories / Index Rebalance

<div><p>The S&amp;P BSE Sensex is the flagship index of the Bombay Stock Exchange (BSE). The index has 30 stocks and is a free float market cap weighted index. The next rebalance will be effective after the close of trading on 18 December.</p></div><div>
<p>The December review uses the market cap and turnover data from 1 May to 31 October to determine the stocks to be included and excluded from the index, and the announcement of the changes is done 4 weeks before the rebalance effective date.</p>
<p><a href="https://www.smartkarma.com/entities/dr-reddy-s-laboratories-ltd" target="_blank" data-smartkarma-citation="entities:16406:1" rel="noopener">Dr. Reddy's Laboratories (DRRD IN)</a> continues to remain a high probability inclusion, and <a href="https://www.smartkarma.com/entities/oil-natural-gas-corp-ltd" target="_blank" data-smartkarma-citation="entities:3456:1" rel="noopener">Oil &amp; Natural Gas Corp (ONGC IN)</a> is the corresponding deletion candidate. There is a lower probability of <a href="https://www.smartkarma.com/entities/britannia-industries-ltd" target="_blank" data-smartkarma-citation="entities:16495:1" rel="noopener">Britannia Industries (BRIT IN)</a> being included in the Sensex, in which case <a href="https://www.smartkarma.com/entities/tata-steel-ltd" target="_blank" data-smartkarma-citation="entities:20934:1" rel="noopener">Tata Steel Ltd (TATA IN)</a> would be deleted.</p>
<p>Since we published our first Insight at the beginning of September, <a href="https://www.smartkarma.com/entities/dr-reddy-s-laboratories-ltd" target="_blank" data-smartkarma-citation="entities:16406:1" rel="noopener">Dr. Reddy's Laboratories (DRRD IN)</a> has outperformed <a href="https://www.smartkarma.com/entities/divi-s-laboratories-ltd" target="_blank" data-smartkarma-citation="entities:4871:1" rel="noopener">Divi'S Laboratories (DIVI IN)</a> by 20% and <a href="https://www.smartkarma.com/entities/torrent-pharmaceuticals-ltd" target="_blank" data-smartkarma-citation="entities:15762:1" rel="noopener">Torrent Pharmaceuticals (TRP IN)</a> by 24%. We would take off the positions and wait for a reversal before re-entering the trade.</p>
<p>The ratio of <a href="https://www.smartkarma.com/entities/oil-natural-gas-corp-ltd" target="_blank" data-smartkarma-citation="entities:3456:1" rel="noopener">Oil &amp; Natural Gas Corp (ONGC IN)</a> to <a href="https://www.smartkarma.com/entities/oil-india-ltd" target="_blank" data-smartkarma-citation="entities:20751:1" rel="noopener">Oil India Ltd (OINL IN)</a> is trading close to its lows providing an entry point into a long ONGC/ short Oil India trade.</p>
<p><em>This Insight is marked as bearish due to Dr Reddy's recent outperformance versus its peers that could revert in the near future.</em></p>
</div>

The S&amp;P BSE Sensex is the flagship index of the Bombay Stock Exchange (BSE). The index has 30 stocks and is a free float market cap weighted index. The next rebalance will be effective after the close of trading on 18 December.
The December review uses the market cap and turnover data from 1 May to 31 October to determine the stocks to be included and excluded from the index, and the announcement of the changes is done 4 weeks before the rebalance effective date.
Dr. Reddy's Laboratories (DRRD IN) continues to remain a high probability inclusion, and Oil &amp; Natural Gas Corp (ONGC IN) is the corresponding deletion candidate. There is a lower probability of Britannia Industries (BRIT IN) being included in the Sensex, in which case Tata Steel Ltd (TATA IN) would be deleted.
Since we published our first Insight at the beginning of September, Dr. Reddy's Laboratories (DRRD IN) has outperformed Divi'S Laboratories (DIVI IN) by 20% and Torrent Pharmaceuticals (TRP IN) by 24%. We would take off the positions and wait for a reversal before re-entering the trade.
The ratio of Oil &amp; Natural Gas Corp (ONGC IN) to Oil India Ltd (OINL IN) is trading close to its lows providing an entry point into a long ONGC/ short Oil India trade.
This Insight is marked as bearish due to Dr Reddy's recent outperformance versus its peers that could revert in the near future.


Sensex Index Rebalance Preview: Take Profit on Strong Outperformance